Zonisamide for essential tremor: An evaluator-blinded study

Movement Disorders

Volumn 24, Issue 3, 2009, Pages 437-440

  Handforth, Adrian ^a,d   Martin, Fredricka C ^a   Kang, Gail A ^b   Vanek, Zeba ^c  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Neurology Service   (United States)

Author keywords

Clinical trial; Essential tremor; Zonisamide

Indexed keywords

ZONISAMIDE; ANTICONVULSIVE AGENT; ISOXAZOLE DERIVATIVE;

ABDOMINAL DISCOMFORT; ARTICLE; BALANCE DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DROWSINESS; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DYSPHAGIA; ESSENTIAL TREMOR; FAHN TOLOSA MARIN SCALE; FEMALE; HUMAN; LONGER SLEEP; MALE; MONOTHERAPY; NAUSEA; POSTURAL TREMOR SCALE; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; RATING SCALE; RHINITIS; SIDE EFFECT; SLEEP; SOMNOLENCE; TASTE DISORDER; AGED; ARM; DRUG ADMINISTRATION; HOSPITALIZATION; PATHOPHYSIOLOGY; SINGLE BLIND PROCEDURE;

AGED; ANTICONVULSANTS; DRUG ADMINISTRATION SCHEDULE; ESSENTIAL TREMOR; FEMALE; HUMANS; ISOXAZOLES; MALE; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; UPPER EXTREMITY;

EID: 67651101178     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22418     Document Type: Article

References (10)

1. Baulac M. Introduction to zonisamide. Epilepsy Res 2006;68 (Suppl 2):S3-S9.
2. Morita S, Miwa H, Kondo T. Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol. Parkinsonism Relat Disord 2005;11:101-103.
3. Findley LJ, Koller WC. Definitions and behavioral classifications. In: Findley LJ, Koller WC, editors. Handbook of tremor disorders. New York: Marcel Dekker; 1995. p 1-5.
4. Handforth A, Martin FC. Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor. Mov Disord 2004;19:1215-1221.
5. Fahn SE, Tolosa E, Marin C. Clinical rating scale for tremor. In: Jankovic J, Tolosa E, editors. Parkinson's disease and movement disorders, 2nd ed. Baltimore: Williams and Wilkins; 1993. p 271-280.
6. Jankovic J, Schwartz K, Clemence W, Aswad A, Mordaunt J. A randomized, double-blind, placebo controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord 1996;11:250-256.
7. Stacy MA, Elble RJ, Ondo WG, Wu SC, Hulihan J; TRS study group. Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor. Mov Disord 2007;22:833-838.
8. Bermejo PE, Ruiz-Huete C, Dorado R, Anciones B. Zonisamide in refractory essential tremor. Rev Neurol 2008;46:139-142.
9. Zesiewicz TA, Ward CL, Hauser RA, Sanchez-Ramos J, Staffetti JF, Sullivan KL. A double-blind placebo-controlled trial of zonisamide (Zonegran) in the treatment of essential tremor. Mov Disord 2007;22:279-282.
10. Ondo WG. Zonisamide for essential tremor. Clin Neuropharmacol 2007;30:345-349.